June 2024 – Maven Bioscience has announced the launch of KindRx, a new division dedicated to creating cutting-edge pet and veterinary products. After years of working behind the scenes producing white-label pet products, the company is now making its mark on the global market with the introduction of the world’s most advanced line of pet and veterinary solutions.
KindRx products are designed for both everyday pet owners and veterinary professionals, offering a range of innovative formulations aimed at improving animal health and wellness. With this global launch, Maven Bioscience is positioning KindRx as a leader in the field, providing high-quality, science-backed solutions for pets.
“KindRx represents the culmination of years of research and development,” said a Maven Bioscience spokesperson. “We’re proud to bring our expertise from the pharmaceutical and precision medicine fields into the pet care industry, delivering products that will set a new standard for pet wellness.”
With this bold move, Maven Bioscience aims to transform the pet care landscape by offering specialized products that blend scientific precision with practical, user-friendly applications for both pet owners and veterinary experts.
